Charles Schwab’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$83.9M Buy
3,040,117
+410,252
+16% +$11.3M 0.01% 759
2025
Q1
$74.6M Buy
2,629,865
+285,662
+12% +$8.1M 0.01% 810
2024
Q4
$97.5M Buy
2,344,203
+211,426
+10% +$8.79M 0.02% 682
2024
Q3
$143M Buy
2,132,777
+83,082
+4% +$5.55M 0.03% 487
2024
Q2
$243M Buy
2,049,695
+82,106
+4% +$9.75M 0.05% 327
2024
Q1
$210M Buy
1,967,589
+96,190
+5% +$10.3M 0.05% 340
2023
Q4
$186M Buy
1,871,399
+70,368
+4% +$7M 0.05% 339
2023
Q3
$186M Buy
1,801,031
+48,851
+3% +$5.05M 0.05% 314
2023
Q2
$213M Sell
1,752,180
-40,127
-2% -$4.88M 0.06% 275
2023
Q1
$275M Buy
1,792,307
+33,844
+2% +$5.2M 0.08% 209
2022
Q4
$316M Buy
1,758,463
+8,824
+0.5% +$1.58M 0.1% 185
2022
Q3
$207M Buy
1,749,639
+114,077
+7% +$13.5M 0.07% 241
2022
Q2
$234M Buy
1,635,562
+12,025
+0.7% +$1.72M 0.08% 238
2022
Q1
$280M Buy
1,623,537
+50,051
+3% +$8.62M 0.08% 216
2021
Q4
$400M Buy
1,573,486
+35,670
+2% +$9.06M 0.12% 155
2021
Q3
$592M Buy
1,537,816
+730,049
+90% +$281M 0.19% 95
2021
Q2
$190M Buy
807,767
+26,621
+3% +$6.26M 0.06% 279
2021
Q1
$102M Buy
781,146
+46,203
+6% +$6.05M 0.04% 444
2020
Q4
$76.8M Buy
734,943
+18,423
+3% +$1.92M 0.03% 541
2020
Q3
$50.7M Sell
716,520
-739,495
-51% -$52.3M 0.02% 660
2020
Q2
$93.5M Buy
1,456,015
+438,140
+43% +$28.1M 0.05% 372
2020
Q1
$30.5M Buy
1,017,875
+176,099
+21% +$5.27M 0.02% 733
2019
Q4
$16.5M Buy
841,776
+22,702
+3% +$444K 0.01% 1351
2019
Q3
$13M Buy
+819,074
New +$13M 0.01% 1425